Latest filing published 25 Jan 2006 for ONYX PHARMACEUTICALS INC, €31k.
Insider track record
No signal scores available.
Scott M. Freeman: trading record in brief
Scott M. Freeman discloses dealings in Onyx Pharmaceuticals Inc to SEC (Form 4). The record holds 4 filings, all for trades on 24 January 2006.
Every open-market trade on record is a sale: 3 sales worth €111k. The rest of the record consists of 1 option exercise.
On 25 January 2006 came the latest disclosure, an option exercise for €31k in Onyx Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott M. Freeman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$7.53Common StockSEC:0001209191-06-005033:0
- 1,139 shares@ US$27.34Common StockSEC:0001209191-06-005033:1
- 200 shares@ US$27.32Common StockSEC:0001209191-06-005033:2
- 3,661 shares@ US$27.31Common StockSEC:0001209191-06-005033:3
4 of 4 declarations
